Tetradecanoylcarnitine
|
Basic information |
| Metabolite name | Tetradecanoylcarnitine |
 | HMDB0005066 |
 |
N/A |
 |
53477791 |
| Synonyms | Tetradecanoyl-L-Carnitine; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Tetradecanoylcarnitine |
| HMDB0005066 |
|
N/A |
|
53477791 |
| Synonyms | Tetradecanoyl-L-Carnitine; |
| No. of studies | 6 |
|
Relationship between Tetradecanoylcarnitine and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M076 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M076 | Type2 | CUMS + Anemarrhena saponins and Lilium saponins group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1021 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M1021 | Type2 | depression group, after 6-month antidepressant treatment vs. baseline | Plasma | Human | Up |
| Study M1097 | Type1 | placebo-treated depression group vs. control group | Faece | Human | Up |
| Study M208 | Type1 | GCI model group vs. control group | Hippocampus | ICR mouse | Up |
| Study M676 | Type1 | CVS group vs. control group | Hippocampus | Wistar rat | Down |
| Study M676 | Type2 | CVS + Chaihu-Shu-Gan-San group vs. CVS group | Hippocampus | Wistar rat | Up |
| Study M870 | Type1 | CRS group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M870 | Type2 | CRS + sertraline group vs. CRS group | Brain | C57BL/6 mouse | Down |
| Study M870 | Type2 | CRS + middle dose of Jia Wei Xiao Yao San group vs. CRS group | Brain | C57BL/6 mouse | Down |